Russell Investments Group Ltd. Has $233.02 Million Stock Position in Cigna Group $CI

Russell Investments Group Ltd. lifted its position in Cigna Group (NYSE:CI) by 2.4% in the second quarter, Holdings Channel.com reports. The institutional investor owned 844,481 shares of the health services provider’s stock after buying an additional 19,937 shares during the period. Russell Investments Group Ltd.’s holdings in Cigna Group were worth $233,023,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CI. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the fourth quarter valued at about $25,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group during the fourth quarter worth about $29,000. Prosperity Bancshares Inc bought a new position in shares of Cigna Group during the 4th quarter valued at about $29,000. Cedar Mountain Advisors LLC lifted its holdings in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares in the last quarter. Finally, ANTIPODES PARTNERS Ltd acquired a new position in shares of Cigna Group in the 2nd quarter valued at approximately $34,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE:CI opened at $282.24 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a fifty day simple moving average of $286.02 and a 200 day simple moving average of $281.28. The stock has a market capitalization of $74.58 billion, a PE ratio of 11.68, a P/E/G ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the company earned $7.20 earnings per share. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, research analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is presently 25.82%.

Analysts Set New Price Targets

CI has been the subject of a number of research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. The Goldman Sachs Group lifted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Barclays upped their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Mizuho increased their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Wells Fargo & Company raised their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Activity

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.